| Literature DB >> 30109260 |
Catherine S Hubbard1,2,3,4,5, Lino Becerra1,2,3, Nicole Heinz6, Allison Ludwick1, Tali Rasooly1, Anastasia Yendiki4,5, Rina Wu6, Neil L Schechter2,3, Samuel Nurko6,7, David Borsook1,2,3.
Abstract
Alterations in fractional anisotropy (FA) have been considered to reflect microstructural white matter (WM) changes in disease conditions; however, no study to date has examined WM changes using diffusion tensor imaging (DTI) in adolescents with irritable bowel syndrome (IBS). The objective of the present study was two-fold: (1) to determine whether differences in FA, and other non-FA metrics, were present in adolescents with IBS compared to healthy controls using whole-brain, region of interest (ROI)-restricted tract-based spatial statistics (TBSS) and canonical ROI DTI analyses for the cingulum bundle, and (2) to determine whether these metrics were related to clinical measures of disease duration and pain intensity in the IBS group. A total of 16 adolescents with a Rome III diagnosis of IBS (females = 12; mean age = 16.29, age range: 11.96-18.5 years) and 16 age- and gender-matched healthy controls (females = 12; mean age = 16.24; age range: 11.71-20.32 years) participated in this study. Diffusion-weighted images were acquired using a Siemens 3-T Trio Tim Syngo MRI scanner with a 32-channel head coil. The ROI-restricted TBSS and canonical ROI-based DTI analyses revealed that adolescents with IBS showed decreased FA in the right dorsal cingulum bundle compared to controls. No relationship between FA and disease severity measures was found. Microstructural WM alterations in the right dorsal cingulum bundle in adolescents with IBS may reflect a premorbid brain state or the emergence of a disease-driven process that results from complex changes in pain- and affect-related processing via spinothalamic and corticolimbic pathways.Entities:
Keywords: DTI; IBS; abdominal pain; functional GI disorders; pediatrics
Mesh:
Year: 2018 PMID: 30109260 PMCID: PMC6090517 DOI: 10.1523/ENEURO.0354-17.2018
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822
Figure 1.JHU WM tract masks used for the ROI-restricted TBSS and canonical ROI-based DTI analyses. Each ROI is color coded and overlaid onto a FMRIB58 FA 1 mm brain template. R Cing. = right cingulum; L Cing. = left cingulum; R Para. Cing. = right parahippocampal cingulum; L Para. Cing. = left parahippocampal cingulum.
Patient characteristics
| Age (years) | Sex | Bowel habit | Current medications | Comorbid conditions | Disease duration | Pain intensity | API | FDI | PedsQL | GI PedsQL | T. anxiety scr | T. anxiety depress. scr | Depress. scr | PSC-C | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 16.43 | F | IBS-C | Antiemetic, antispasmodic, laxative, PPI | - | 3.0 | 2.08 | 2.45 | 7 | - | - | 16 | 23 | 48 | - |
| 2 | 16.90 | F | IBS-D | None | ACNES | 1.5 | 1.95 | 1.78 | 15 | - | - | - | - | - | - |
| 3 | 13.28 | F | IBS-C | Antiemetic, PPI | - | 2.0 | 1.95 | 2.15 | 30 | 51.09 | 48.31 | 24 | 37 | 63 | 3.22 |
| 4 | 17.59 | M | IBS-D | Antiemetic, antihistamine, antispasmodic, stool softener | - | 5.0 | 1.95 | 1.78 | 22 | 76.09 | 68.24 | 9 | 15 | 47 | 2.77 |
| 5 | 17.07 | M | IBS-D | Antacid, antiemetic | - | 3.5 | 2.20 | 2.48 | 38 | 36.96 | 53.38 | 42 | 50 | 52 | 3.74 |
| 6 | 17.55 | F | IBS-C | GCC agonist, PPI | - | 1.0 | 1.95 | 3.30 | 14 | 60.87 | 50.68 | 21 | 39 | 66 | - |
| 7 | 16.46 | F | IBS-C | Antidepressant (SSRI) | ACNES | 2.0 | 2.08 | 3.30 | 14 | 63.04 | 46.28 | 31 | 43 | 56 | 3.56 |
| 8 | 18.50 | F | IBS-U | Antacid, antihistamine, β-blocker, NSAID, opioid analgesic (meperidine), sedative (ambien), TCA | - | 2.0 | 2.08 | 3.80 | 30 | 50.00 | 54.0 | 36 | 52 | 71 | 3.74 |
| 9 | 15.86 | F | IBS-C | Antihistamine, NSAID, PPI, antidepressant (TCA), levothyroxine (TH) | Ehlers-Danlos, arthritis | 6.0 | 2.08 | 3.28 | 43 | 35.86 | 38.17 | 60 | 82 | 81 | 3.09 |
| 10 | 18.30 | F | IBS-C | GCC agonist, PPI, muscle relaxant, anti-inflammatory | - | 6.0 | 2.30 | 3.00 | 10 | 64.13 | 37.16 | 15 | 23 | 47 | 2.64 |
| 11 | 16.67 | F | IBS-M | Anti-inflammatory, β-blocker, PPI, SRA (triptan), TCA | Possible POTS, occasional migraine | 5.0 | 2.08 | 2.53 | 30 | 63.04 | 57.77 | 7 | 18 | 54 | 2.89 |
| 12 | 16.87 | M | IBS-D | Antihistamine, PPI | - | 3.0 | 2.20 | 2.60 | 10 | 80.43 | 75.34 | 12 | 22 | 57 | 2.89 |
| 13 | 15.06 | F | IBS-M | Antispasmodic, laxative | - | 1.0 | 2.20 | 2.88 | 21 | - | - | 8 | 11 | 35 | - |
| 14 | 14.65 | F | IBS-C | Antidepressant (SNRI), laxative | - | 7.0 | 2.20 | 3.80 | 12 | 60.87 | 62.50 | 25 | 39 | 67 | 3.22 |
| 15 | 11.96 | F | IBS-C | Inhaled, corticosteroid, laxative, PPI, stool softener, TCA | - | 8.0 | 2.08 | 1.65 | 24 | 52.17 | 64.58 | 24 | 32 | 8 | 3.43 |
| 16 | 17.50 | M | IBS-C | Antihistamine, laxative, PPI | Barrett’s esophagus | 10.0 | 2.08 | 1.35 | 21 | 81.51 | 60.47 | 23 | 30 | 49 | 2.77 |
ACNES = anterior cutaneous nerve entrapment syndrome; GCC = guanylate cyclase C agonist; NSAID = non-steroidal anti-inflammatory drug; SNRI = selective norepinephrine reuptake inhibitor; SSRI = selective-serotonin reuptake inhibitor; SRA = serotonin receptor agonist; TCA = tricyclic antidepressant; TH = thyroid hormone; PPI = proton-pump inhibitor; POTS = postural orthostatic tachycardia syndrome; API = abdominal pain index; FDI = functional; disability inventory; PedsQL = pediatric quality of life inventory; PedsQL GI = pediatric quality of life inventory gastrointestinal symptoms module; T. anxiety scr = total anxiety score; T. anxiety depress. scr = total anxiety depression score; Depress. scr = Depression score; PCS-C pain catastrophizing scale– child version.
Descriptive statistics for clinical and psychometric measures
| IBS patients | |||
|---|---|---|---|
| Mean | SD | ||
| Disease duration (years) | 4.125 | 2.699 | 16 |
| Pain intensity | 8.125 | 0.885 | 16 |
| API | 2.633 | 0.757 | 16 |
| FDI | 21.313 | 10.575 | 16 |
| PedsQL (total score) | 59.698 | 14.517 | 13 |
| GI PedsQL (total score) | 55.148 | 11.250 | 13 |
| RCADS - total anxiety score | 23.533 | 14.342 | 15 |
| RCADS - total anxiety depression score | 34.400 | 18.074 | 15 |
| RCADS - depression score | 53.400 | 17.029 | 15 |
| PCS-C | 25.333 | 10.012 | 12 |
n = sample size; API = abdominal pain index; FDI = functional; disability inventory; PedsQL = pediatric quality of life inventory; PedsQL GI = pediatric quality of life inventory gastrointestinal symptoms module; PCS-C = pain catastrophizing scale – child version; RCADS = revised children's anxiety and depression scale; SD = standard deviation.
Figure 2.Results from the ROI-restricted TBSS group analysis for the right dorsal cingulum. , ROI-restricted TBSS analysis revealed a significant decrease in FA in adolescents with IBS compared to non-IBS cohort (IBS patients < healthy controls; p < 0.05, TFCE corrected; color bar is scaled from 0.95 to 1) for a cluster located in the right dorsal cingulum. TFCE-corrected map overlaid onto MNI 152 T1 1-mm brain and thresholded (0.2) mean FA skeleton (green) template in FSLView (version 3.2.0) with superimposed JHU binary mask for the right dorsal cingulum shown in pink. To improve visualization, FSL’s tbss-fill command was used to thicken tracts that showed significant group differences in FA. MNI coordinates for the peak voxel in the FA cluster are x = 8.83, y = 3.5, z = 33.6. Images are displayed in radiologic orientation. , Bar graph showing mean values extracted from significant FA cluster in IBS patients and healthy controls, F(1,28) = 12.22, p = 0.002. Asterisk denotes significant group differences with IBS patients showing decreased FA compared to healthy controls.
Figure 3.Results derived from the canonical ROI-based DTI analysis for the right dorsal cingulum. Bar graphs showing mean FA, MD, and RD values extracted from the right dorsal cingulum ROI in IBS patients (white bars) versus healthy controls (black bars). Asterisk denotes significant group differences with IBS patients showing decreased FA compared to healthy controls for the right dorsal cingulum (p = 0.028).
Descriptive statistics for mean FA, MD, and RD extracted from the right dorsal cingulum ROI for IBS and healthy control groups for the ROI-restricted TBSS and ROI-based DTI analyses
| IBS ( | Controls ( | ||||
|---|---|---|---|---|---|
| Method | DTI Metric | Mean | SD | Mean | SD |
| ROI-restricted TBSS | FA | 0.500 | 0.067 | 0.582 | 0.070 |
| MD | 6.90 × 10-4 | 5.46 × 10-5 | 6.90 × 10-4 | 5.64 × 10-5 | |
| RD | 4.85 × 10-4 | 6.44 × 10-5 | 4.35 × 10-4 | 6.65 × 10-5 | |
| Canonical ROI-based DTI | FA | 0.400 | 0.029 | 0.424 | 0.032 |
| MD | 7.56 × 10-4 | 2.90 × 10-5 | 7.53 × 10-4 | 2.23 × 10-5 | |
| RD | 5.84 × 10-4 | 3.54 × 10-5 | 5.68 × 10-4 | 2.86 × 10-5 | |
ROI = region of interest; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity; n = sample size; SD = standard deviation.
Figure 4.Heat map summarizing Pearson correlation coefficients (r) for clinical and psychometric measures, uncorrected for multiple comparisons. Asterisk denotes correlation that remained significant after Bonferroni adjustment (adjusted p value = 0.05/45 = 0.001).